Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Mune, Masatoshi ^a   Yukawa, Susumu ^a   Kishino, Masanori ^a   Otani, Haruhisa ^a   Kimura, Keigo ^a   Nishikawa, Osamu ^a   Takahashi, Toshio ^a   Kodama, Naoya ^a   Saika, Yasushi ^a   Yamada, Yoichi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti oxidant vitamins; Atherogenesis; End stage renal disease; Hemodialysis; Oxidized LDL

Indexed keywords

ALPHA TOCOPHEROL; LIPID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; ASCORBIC ACID;

AGED; AORTA DISEASE; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CALCINOSIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIPID METABOLISM; MALE; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; ADULT; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONFERENCE PAPER; KIDNEY FAILURE; OXIDATIVE STRESS; PRIORITY JOURNAL; VITAMIN METABOLISM;

AGED; AORTIC DISEASES; ARTERIOSCLEROSIS; CALCINOSIS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID METABOLISM; LIPIDS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; RENAL DIALYSIS; VITAMIN E;

EID: 0033050487     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. LINDNER A, CHARRA B, SHERRARD DJ, SCRIBNER BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
2. BONOMINI V, FELETTI C, SCOLARI MP, STEFONI S, VANGELISTA A: Atherosclerosis in uremia: A longitudinal study. Am J Clin Nutr 33:1493-1500, 1980
3. BROWN MS, GOLDSTEIN JL: Lipoprotein metabolism in macrophages. Annu Rev Biochem 52:223-261, 1983
4. YUKAWA S, HIBINO A, MAEDA T, MIMURA K, YUKAWA A, MAEDA A, KISHINO M, SONOBE M, MUNE M, YAMADA Y, NISIDE I: Effect of α-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients. Nephrol Dial Transplant 10(Suppl 3):1-3, 1995
5. JACKSON P, LOUGHREY CM, LIGHTBODY JH, MCNAMEE PT, YOUNG IS: Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 41:1135-1138, 1995
6. MAGGI E, BELLAZZI R, FALASCHI F, FRATTONI A, PERANI G, FINARDI G, GAZO A, NAI M, ROMANINI D, BELLOMO G: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 45:876-883, 1994
7. YUKAWA S, SONOBE M, TONE Y, YUKAWA A, MIMURA K, MUNE M, MAEDA T, NOMOTO H, NISHIDE I: Prevention of aortic calcification in patients on hemodialysis by long-term administration of vitamin E. J Nutr Science Vitaminol Special Number:187-190, 1992
8. SARUHASHI M, WATANABE H, SASAKI M: Biocompatibility of vitamin E-modified regenerated cellulose. Jpn J Artif Organs 24:631-636, 1995
9. GALLI F, ROVIDATI S, CHIARANTINI L, CAMPUS G, CANESTRARI F, BUONCRISTIANI U: Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int 54:580-589, 1998
10. ITABE H, TAKESHIMA E, IWASAKI H, KIMURAJ, YOSHIDA Y, IMANAKA T, TAKANO T: A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. J Biol Chem 269:15274-15279, 1994